Arie Belldegrun Insider Trading $ARNI Arno Therapeutics, Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Arie Belldegrun.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Arie Belldegrun. Arie Belldegrun is Director in Arno Therapeutics, Inc ($ARNI).
Arie Belldegrun in Arno Therapeutics, Inc
Trading Symbol: ARNIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Arie Belldegrun: Director
Holdings: 100,481 shares
Current Value: $8,038
Latest Transaction: Jan 28 2014
$ARNI Market Capitalization: $4.19M
$ARNI Previous Close: $0.08
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Arie Belldegrun in Arno Therapeutics, Inc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 28 2014 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | A | 2.90 | 68,448 | 198,499 | 68,448 | |
Nov 06 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | A | 2.40 | 3,559,296 | 8,542,310 | 3,559,296 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | A | 2.40 | 83,333 | 199,999 | 83,333 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | D | 2.40 | 83,333 | 199,999 | 0 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | C | 2.40 | 83,333 | 199,999 | 0 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | P | 2.40 | 83,333 | 199,999 | 83,333 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | P | 4.00 | 83,333 | 333,332 | 83,333 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | A | 2.40 | 62,500 | 150,000 | 62,500 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | D | 2.40 | 62,500 | 150,000 | 0 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | C | 2.40 | 62,500 | 150,000 | 0 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Grant | A | 2.40 | 6,666 | 15,998 | 100,481 | 93.8 K to 100.5 K (+7.11 %) |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | C | 2.40 | 88,871 | 213,290 | 93,815 | 4.9 K to 93.8 K (+1,797.55 %) |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | P | 0.00 | 83,332 | 0 | 174,644 | 91.3 K to 174.6 K (+91.26 %) |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Grant | A | 2.40 | 5,000 | 12,000 | 91,312 | 86.3 K to 91.3 K (+5.79 %) |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | C | 2.40 | 66,652 | 159,965 | 86,312 | 19.7 K to 86.3 K (+339.02 %) |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | P | 2.40 | 187,500 | 450,000 | 187,500 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | P | 4.00 | 187,500 | 750,000 | 187,500 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | A | 2.40 | 145,833 | 349,999 | 145,833 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | D | 2.40 | 145,833 | 349,999 | 0 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | C | 2.40 | 145,833 | 349,999 | 0 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | P | 2.40 | 104,166 | 249,998 | 104,166 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | P | 4.00 | 104,166 | 416,664 | 104,166 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | A | 2.40 | 125,000 | 300,000 | 125,000 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | D | 2.40 | 125,000 | 300,000 | 0 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | C | 2.40 | 125,000 | 300,000 | 0 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | P | 2.40 | 104,166 | 249,998 | 104,166 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Option Exercise | P | 4.00 | 104,166 | 416,664 | 104,166 | |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | P | 0.00 | 187,500 | 0 | 379,294 | 191.8 K to 379.3 K (+97.76 %) |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Grant | A | 2.40 | 11,666 | 27,998 | 191,794 | 180.1 K to 191.8 K (+6.48 %) |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | C | 2.40 | 155,523 | 373,255 | 180,128 | 24.6 K to 180.1 K (+632.08 %) |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | P | 0.00 | 104,166 | 0 | 254,887 | 150.7 K to 254.9 K (+69.11 %) |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Grant | A | 2.40 | 10,000 | 24,000 | 150,721 | 140.7 K to 150.7 K (+7.11 %) |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | C | 2.40 | 133,305 | 319,932 | 140,721 | 7.4 K to 140.7 K (+1,797.53 %) |
Nov 05 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | P | 0.00 | 104,166 | 0 | 143,809 | 39.6 K to 143.8 K (+262.76 %) |
Jun 03 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 12,889 | 3,867 | 39,555 | 26.7 K to 39.6 K (+48.33 %) |
Jun 03 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 9,667 | 2,900 | 157,286 | 147.6 K to 157.3 K (+6.55 %) |
Jun 03 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 22,556 | 6,767 | 196,841 | 174.3 K to 196.8 K (+12.94 %) |
Jun 03 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 19,333 | 5,800 | 59,333 | 40 K to 59.3 K (+48.33 %) |
May 07 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 13,333 | 4,000 | 26,666 | 13.3 K to 26.7 K (+100.00 %) |
May 07 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 10,000 | 3,000 | 147,619 | 137.6 K to 147.6 K (+7.27 %) |
May 07 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 23,333 | 7,000 | 174,285 | 151 K to 174.3 K (+15.46 %) |
May 07 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 20,000 | 6,000 | 40,000 | 20 K to 40 K (+100.00 %) |
Apr 15 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 13,333 | 4,000 | 13,333 | 0 to 13.3 K |
Apr 15 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 10,000 | 3,000 | 137,619 | 127.6 K to 137.6 K (+7.84 %) |
Apr 15 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 23,333 | 7,000 | 150,952 | 127.6 K to 151 K (+18.28 %) |
Apr 15 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 20,000 | 6,000 | 20,000 | 0 to 20 K |
Page: 1